| |
| |
|
| Insider
Information: |
Ingram Douglas S |
| Relationship: |
Director |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
444,936 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$49,599,744 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
444,936 |
|
|
| Total
Value |
$49,599,744 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
2
|
|
Stock
price went up :
|
2
|
2
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
| Percentage
Gain/Loss : |
 27.2%
|
96.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ECC Capital Corporation |
ECRO |
Director |
2005-02-18 |
29,629 |
2005-02-18 |
0 |
Premium* |
|
|
Volcom Inc |
VLCM |
Director |
2011-06-16 |
0 |
2006-08-03 |
0 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
President & CEO, Direc... |
2023-11-03 |
390,307 |
2017-06-26 |
0 |
Premium* |
|
|
Relay Therapeutics, Inc. |
RLAY |
Director |
2020-07-20 |
25,000 |
2020-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2023-11-03 |
4 |
B |
$78.57 |
$2,001,800 |
D/D |
25,225 |
390,307 |
2.81 |
% |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2021-11-17 |
4 |
B |
$79.94 |
$2,000,578 |
D/D |
25,026 |
365,082 |
2.81 |
% |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2021-06-26 |
4 |
D |
$80.40 |
$1,432,085 |
D/D |
(17,812) |
340,056 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
Director |
– • – |
2020-07-20 |
4 |
B |
$20.00 |
$500,000 |
D/D |
25,000 |
25,000 |
2.39 |
% |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2019-12-31 |
4 |
D |
$129.04 |
$4,798,352 |
D/D |
(37,185) |
395,012 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2019-08-12 |
4 |
B |
$122.76 |
$2,000,160 |
D/D |
16,252 |
432,197 |
2.81 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2018-10-30 |
4 |
B |
$120.26 |
$2,009,872 |
D/D |
16,695 |
415,945 |
2.81 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2018-08-15 |
4 |
B |
$125.26 |
$2,004,211 |
D/D |
16,000 |
399,250 |
2.81 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2018-06-26 |
4 |
D |
$135.53 |
$5,007,291 |
D/D |
(36,946) |
383,250 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2017-11-08 |
4 |
B |
$52.44 |
$1,999,957 |
D/D |
38,138 |
420,196 |
2.81 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2017-07-27 |
4 |
B |
$42.50 |
$1,999,965 |
D/D |
47,058 |
382,058 |
2.81 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
President & CEO |
• • – |
2017-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
335,000 |
335,000 |
0 |
- |
|
| VLCM |
Volcom Inc |
Director |
– • – |
2011-06-16 |
4 |
D |
$24.50 |
$61,250 |
D/D |
(2,500) |
0 |
0 |
- |
|
| VLCM |
Volcom Inc |
Director |
– • – |
2006-08-03 |
4 |
B |
$19.23 |
$48,118 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
| ECRO |
ECC Capital Corporation |
Director |
– • – |
2005-02-18 |
4 |
B |
$6.75 |
$199,996 |
D/D |
29,629 |
29,629 |
2.39 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
